MedTrace Logo

Active Surveillance for Limited GGNs

NCT06394037 · Status: NOT_YET_RECRUITING · Type: OBSERVATIONAL · Enrollment: 387

Last updated 2025-01-31

No results posted yet for this study

Summary

This study is a single-arm, multi-center, phase III trial conducted under the Eastern Cooperative Thoracic Oncoloy Project (ECTOP) . The primary objective of the study is to assess the 5-year overall survival of patients with one or two ground-glass opacities by employing an active surveillance approach rather than immediate surgical resection.

Conditions

  • Lung Ground-glass Opacities
  • Active Surveillance

Interventions

PROCEDURE

Active surveillance

Conduct thoracic computed tomography scans every 12 months. If progression occurs, the treamtent approach would involve surgery.

Sponsors & Collaborators

  • Fudan University

    lead OTHER

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-05-01
Primary Completion
2038-05-01
Completion
2038-05-01

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06394037 on ClinicalTrials.gov